Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats

Molecular Nutrition and Food Research

Volumn 59, Issue 11, 2015, Pages 2326-2336

  Gómez Guzmán, Manuel ^a   Toral, Marta ^a   Romero, Miguel ^a,b   Jiménez, Rosario ^a,b   Galindo, Pilar ^a   Sánchez, Manuel ^a   Zarzuelo, María José ^a   Olivares, Mónica ^d   Gálvez, Julio ^b,c   Duarte, Juan ^a,b  

^a UNIVERSITY OF GRANADA   (Spain)

^b Instituto De Investigación Biosanitaria de Granada Ibs GRANADA   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

^d Department of Analytical Services Biosearch S A   (Spain)

Author keywords

Endothelial dysfunction; Gut microbiota; Hypertension; Probiotic bacteria; SHR

Indexed keywords

ANTIHYPERTENSIVE AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, RAT; PROBIOTIC AGENT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL; BLOOD PRESSURE; DRUG EFFECTS; ENDOTHELIUM CELL; INTESTINE FLORA; LACTOBACILLUS; MALE; METABOLISM; PHYSIOLOGY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULITIS; WISTAR KYOTO RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; ENDOTHELIAL CELLS; GASTROINTESTINAL MICROBIOME; LACTOBACILLUS; MALE; NADPH OXIDASE; NITRIC OXIDE SYNTHASE TYPE III; PROBIOTICS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REACTIVE OXYGEN SPECIES; VASCULITIS;

EID: 84940951079     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500290     Document Type: Article

References (54)

1. Turnbull, F., Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003, 362, 1527-1535.
2. Mancia, G., Fagard, R., Narkiewicz, K., Redon, J. et al., 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press. 2014, 23, 3-16.
3. Dinh, Q. N., Drummond, G. R., Sobey, C. G., Chrissobolis, S., Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed. Res. Int. 2014, 2014, 406960.
4. Hill, C., Guarner, F., Reid, G., Gibson, G. R. et al., Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014, 11, 506-514.
5. Cani, P. D., Delzenne, N. M., The role of the gut microbiota in energy metabolism and metabolic disease. Curr. Pharm. Des. 2009, 15, 1546-1558.
6. Singh, V. P., Sharma, J., Babu, S., Rizwanulla et al., Role of probiotics in health and disease: a review. J. Pak. Med. Assoc. 2013, 63, 253-257.
7. Yang, T., Santisteban, M. M., Rodriguez, V., Li, E. et al., Gut dysbiosis is linked to hypertension. Hypertension. 2015, 65, 1331-1340.
8. Rerksuppaphol, S., Rerksuppaphol, L., A randomized double-blind controlled trial of Lactobacillus acidophilus plus bifidobacterium bifidum versus placebo in patients with hypercholesterolemia. J. Clin. Diagn. Res. 2015, 9, KC01-KC04.
9. Ishimwe, N., Daliri, E. B., Lee, B. H., Fang, F. et al., The perspective on cholesterol-lowering mechanisms of probiotics. Mol. Nutr. Food Res. 2015, 59, 94-105.
10. Gan, X. T., Ettinger, G., Huang, C. X., Burton, J. P. et al., Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat. Circ. Heart Fail. 2014, 7, 491-499.
11. Liong, M. T., Probiotics: a critical review of their potential role as antihypertensives, immune modulators, hypocholesterolemics, and perimenopausal treatments. Nutr. Rev. 2007, 65, 316-328.
12. Lye, H. S., Kuan, C. Y., Ewe, J. A., Fung, W. Y. et al., The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. Int. J. Mol. Sci. 2009, 10, 3755-3775.
13. Khalesi, S., Sun, J., Buys, N., Jayasinghe, R., Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials. Hypertension 2014, 64, 897-903.
14. Matsuzaki, T., Takagi, A., Ikemura, H., Matsuguchi, T. et al., Intestinal microflora: probiotics and autoimmunity. J. Nutr. 2007, 137, 798S-802S.
15. Arribas, B., Rodríguez-Cabezas, M. E., Comalada, M., Bailón, E. et al., Evaluation of the preventative effects exerted by Lactobacillus fermentum in an experimental model of septic shock induced in mice. Br. J. Nutr. 2009, 101, 51-58.
16. Arribas, B., Garrido-Mesa, N., Perán, L., Camuesco, D. et al., The immunomodulatory properties of viable Lactobacillus salivarius ssp. salivarius CECT5713 are not restricted to the large intestine. Eur. J. Nutr. 2012, 51, 365-374.
17. Ba, D., Takeichi, N., Kodama, T., Kobayashi, H., Restoration of T cell depression and suppression of blood pressure in spontaneously hypertensive rats (SHR) by thymus grafts or thymus extracts. J. Immunol. 1982, 128, 1211-1216.
18. Pascual, V. H., Oparil, S., Eldridge, J. H., Jin, H. et al., Spontaneously hypertensive rat: lymphoid depression is age dependent and mediated via a mononuclear cell subpopulation. Am. J. Physiol. 1992, 262, R1-R7.
19. Takeichi, N., Suzuki, K., Okayasu, T., Kobayashi, H., Immunological depression in spontaneously hypertensive rats. Clin. Exp. Immunol. 1980, 40, 120-126.
20. Díaz-Ropero, M. P., Martín, R., Sierra, S., Lara-Villoslada, F. et al., Two Lactobacillus strains, isolated from breast milk, differently modulate the immune response. J. Appl. Microbiol. 2007, 102, 337-343.
21. Olivares, M., Díaz-Ropero, M. P., Gómez, N., Lara-Villoslada, F. et al., The consumption of two new probiotic strains, Lactobacillus gasseri CECT 5714 and Lactobacillus coryniformis CECT 5711, boosts the immune system of healthy humans. Int. Microbiol. 2006, 9, 47-52.
22. Vera, R., Jiménez, R., Lodi, F., Sánchez, M. et al., Genistein restores caveolin-1 and AT-1 receptor expression and vascular function in large vessels of ovariectomized hypertensive rats. Menopause 2007, 14, 933-940.
23. Zarzuelo, M. J., Jiménez, R., Galindo, P., Sánchez, M. et al., Antihypertensive effects of peroxisome proliferator-activated receptor-β activation in spontaneously hypertensive rats. Hypertension 2011, 58, 733-743.
24. Quintela, A. M., Jiménez, R., Gómez-Guzmán, M., Zarzuelo, M. J. et al., Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats. Free Radic. Biol. Med. 2012, 53, 730-741.
25. Freeman, W. M., Walker, S. J., Vrana, K. E., Quantitative RT-PCR: pitfalls and potential. Biotechniques 1999, 26, 112-122, 124-125.
26. Garrido-Mesa, N., Utrilla, P., Comalada, M., Zorrilla, P. et al., The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice. Biochem. Pharmacol. 2011, 82, 1891-1900.
27. Toral, M., Gómez-Guzmán, M., Jiménez, R., Romero, M. et al., The probiotic Lactobacillus coryniformis CECT5711 reduces vascular pro-oxydant and pro-inflammatory status in obese mice. Clin. Sci. (Lond) 2014, 127, 33-45.
28. Vanhoutte, P. M., Miller, V. M., Heterogeneity of endothelium-dependent responses in mammalian blood vessels. J. Cardiovasc. Pharmacol. 1985, 7, S12-S23.
29. Vincent, M. A., Montagnani, M., Quon, M. J., Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium. Curr. Diab. Rep. 2003, 3, 279-288.
30. Tschudi, M. R., Mesaros, S., Lüscher, T. F., Malinski, T., Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension. Hypertension 1996, 27, 32-35.
31. Kobayasi, R., Akamine, E. H., Davel, A. P., Rodrigues, M. A. et al., Oxidative stress and inflammatory mediators contribute to endothelial dysfunction in high-fat diet-induced obesity in mice. J. Hypertens. 2010, 28, 2111-2119.
32. Roberts, C. K., Barnard, R. J., Sindhu, R. K., Jurczak, M. et al., A high-fat, refined-carbohydrate diet induces endothelial dysfunction and oxidant/antioxidant imbalance and depresses NOS protein expression. J. Appl. Physiol. 2005, 98, 203-210.
33. Grunfeld, S., Hamilton, C. A., Mesaros, S., McClain, S. W. et al., Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 1995, 26, 854-857.
34. Suzuki, H., Swei, A., Zweifach, B. W., Schmid-Schönbein, G.W., In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hydroethidine microfluorography. Hypertension 1995, 25, 1083-1089.
35. Wind, S., Beuerlein, K., Armitage, M. E., Taye, A. et al., Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition. Hypertension 2010, 56, 490-497.
36. Vila, E., Salaices, M., Cytokines and vascular reactivity in resistance arteries. Am. J. Physiol. Heart Circ. Physiol. 2005, 288, H1016-H1021.
37. Bomfim, G. F., Dos Santos, R. A., Oliveira, M. A., Giachini, F. R. et al., Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats. Clin. Sci. (Lond). 2012, 122, 535-543.
38. Eissler, R., Schmaderer, C., Rusai, K., Kühne, L. et al., Hypertension augments cardiac Toll-like receptor 4 expression and activity. Hypertens. Res. 2011, 34, 551-558.
39. Sollinger, D., Eißler, R., Lorenz, S., Strand, S. et al., Damage-associated molecular pattern activated Toll-like receptor 4 signalling modulates blood pressure in L-NAME-induced hypertension. Cardiovasc. Res. 2014, 101, 464-472.
40. Liang, C. F., Liu, J. T., Wang, Y., Xu, A. et al., Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4. Arterioscler. Thromb. Vasc. Biol. 2013, 33, 777-784.
41. Pluznick, J. L., Protzko, R. J., Gevorgyan, H., Peterlin, Z. et al., Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc. Natl. Acad. Sci. USA 2013, 110, 4410-4415.
42. Bennett, B. J., de Aguiar Vallim, T. Q., Wang, Z., Shih, D. M. et al., Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 2013, 17, 49-60.
43. Cani, P. D., Osto, M., Geurts, L., Everard, A., Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 2012, 3, 279-288.
44. Samuel, B. S., Shaito, A., Motoike, T., Rey, F. E. et al., Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc. Natl. Acad. Sci. USA 2008, 105, 16767-16772.
45. Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J. et al., Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009, 461, 1282-1286.
46. Lathrop, S. K., Bloom, S. M., Rao, S. M., Nutsch, K. et al., Peripheral education of the immune system by colonic commensal microbiota. Nature 2011, 478, 250-254.
47. Queipo-Ortuño, M. I., Boto-Ordóñez, M., Murri, M., Gomez-Zumaquero, J. M. et al., Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am. J. Clin. Nutr. 2012, 95, 1323-1334.
48. Clemente-Postigo, M., Queipo-Ortuño, M. I., Boto-Ordoñez, M., Coin-Aragüez, L. et al., Effect of acute and chronic red wine consumption on lipopolysaccharide concentrations. Am. J. Clin. Nutr. 2013, 97, 1053-1061.
49. Xu, P., Li, M., Zhang, J., Zhang, T., Correlation of intestinal microbiota with overweight and obesity in Kazakh school children. BMC Microbiol. 2012, 12, 283.
50. Grangette, C., Bifidobacteria and subsets of dendritic cells: friendly players in immune regulation! Gut. 2012, 61, 331-332.
51. Olivares, M., Díaz-Ropero, M. P., Martín, R., Rodríguez, J. M. et al., Antimicrobial potential of four Lactobacillus strains isolated from breast milk. J. Appl. Microbiol. 2006, 101, 72-79.
52. Frohlich, E. D., Apstein, C., Chobanian, A. V., Devereux, R. B. et al., The heart in hypertension. N. Engl. J. Med. 1992, 327, 998-1008.
53. Gan, X. T., Ettinger, G., Huang, C. X., Burton, J. P. et al., Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat. Circ. Heart Fail. 2014, 7, 491-499.
54. Rodríguez, A., Frühbeck, G., Gómez-Ambrosi, J., Catalán, V. et al., The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats. J. Hypertens. 2006, 24, 1589-1597.